Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Quince Therapeutics, Inc. (CRTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/17/2023 SC 13G BML Investment Partners, L.P. reports a 5.1% stake in Quince Therapeutics, Inc.
03/31/2023 SC 13G TANG CAPITAL PARTNERS LP reports a 10% stake in Quince Therapeutics, Inc.
02/16/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/16/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/16/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/30/2019 SC 13G LAMOND PIERRE reports a 10.8% stake in Cortexyme, Inc.
09/30/2019 SC 13G Lamond David reports a 7.2% stake in Cortexyme, Inc.
06/11/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/22/2019 SC 13G PFIZER INC reports a 12.2% stake in Cortexyme, Inc.
05/20/2019 SC 13G TAKEDA PHARMACEUTICAL CO LTD reports a 9.9% stake in CORTEXYME, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy